In line with ACR rules, allopurinol is strongly advised as a primary-line urate-decreasing medication. Genetic screening is suggested (for the variant referred to as HLA B*5801) before commencing allopurinol because the carriers of the gene are at an increased danger of the severe allergic reaction.Dengan mencegah serangan ini, anda dapat mengawal